1. DOP11 Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis. (25th January 2019) Authors: Slevin, S; Tan, M; Lahiff, C; Wang, L M; Greenaway, B; Lynch, K; Geremia, A; Hughes, S; Leavens, K; Nevin, K; Marks, D J B; Tarzi, R; Srinivasan, N; Travis, S; Arancibia, C; Keshav, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP28 Host–microbial crosstalk in the pathogenesis of inflammation and cancer in primary sclerosing cholangitis. (25th January 2019) Authors: Neyazi, M; Ilott, N; Travis, S; Arancibia, C; Powrie, F; Geremia, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S59 Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae. (11th November 2022) Authors: Brown, MA; Morgan, SB; Donachie, G; Horton, KL; Pavord, ID; Arancibia, C; Hinks, TSC Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗